Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary
- PMID: 24832842
- DOI: 10.1007/s10198-014-0600-x
Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary
Abstract
Background: There is a growing interest in policy making for using utility measures and identifying algorithms to convert disease-specific measures into utilities.
Objectives: To analyse the relationship between EQ-5D, Dermatology Life Quality Index (DLQI) and Psoriasis Area and Severity Index (PASI) in psoriasis. To transform DLQI scores, and key clinical, demographic and health service utilisation variables into utilities.
Methods: A cross-sectional questionnaire survey of 200 consecutive adult patients with moderate to severe psoriasis was carried out in two Hungarian university clinics. The relationship between the outcome measures were analysed with correlations and with the known-groups method. Bivariate and multivariate regression algorithms on EQ-5D scores were formulated.
Results: The mean age of respondents was 51 years (SD = 12.9), 68.5% were male, and 51.5% received biological therapy. Median EQ-5D, DLQI, and PASI scores were 0.73, 3.0, and 3.45, respectively. EQ-5D showed a moderate correlation with the DLQI and with the PASI (r s = -0.48 and -0.43, p < 0.05). Strong correlation was found between DLQI and PASI (r s = 0.81, p < 0.05). DLQI and PASI discriminated better among groups categorised by the localisation of the lesions than EQ-5D. Presence of psoriasis on the neck and/or décolletage was associated with the greatest health related quality of life (HRQOL) impairment. Ten variables were incorporated in a multivariate algorithm that accounted for 48.8% of EQ-5D variance (ANOVA p < 0.001).
Conclusions: This study provided the first evidence that patients with visible psoriatic lesions have significantly worse HRQOL compared to those with non-visible lesions, measured not only with DLQI but also with EQ-5D. In addition to demographic and clinical variables, our model included health service utilisation variables related to psoriasis, and explained higher proportion of EQ-5D variance than any previous findings in the literature.
Similar articles
-
[Assessment of health-related quality of life in psoriasis patients in Hungary].Orv Hetil. 2018 May;159(21):837-846. doi: 10.1556/650.2018.31061. Orv Hetil. 2018. PMID: 29779387 Hungarian.
-
Analysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patients.Br J Dermatol. 2012 Apr;166(4):797-802. doi: 10.1111/j.1365-2133.2011.10778.x. Epub 2012 Mar 12. Br J Dermatol. 2012. PMID: 22182212
-
Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis.Value Health. 2018 Aug;21(8):1010-1018. doi: 10.1016/j.jval.2017.10.024. Epub 2017 Dec 26. Value Health. 2018. PMID: 30098665
-
Health state utility values derived from EQ-5D in psoriatic patients: a systematic review and meta-analysis.J Dermatolog Treat. 2022 Mar;33(2):1029-1036. doi: 10.1080/09546634.2020.1800571. Epub 2020 Aug 9. J Dermatolog Treat. 2022. PMID: 32716651
-
Moderate Psoriasis: A Proposed Definition.Actas Dermosifiliogr. 2017 Dec;108(10):911-917. doi: 10.1016/j.ad.2017.07.002. Epub 2017 Aug 17. Actas Dermosifiliogr. 2017. PMID: 28823420 Review. English, Spanish.
Cited by
-
Biologicals and small molecules in psoriasis: A systematic review of economic evaluations.PLoS One. 2018 Jan 3;13(1):e0189765. doi: 10.1371/journal.pone.0189765. eCollection 2018. PLoS One. 2018. PMID: 29298315 Free PMC article.
-
Cost-Effectiveness Analysis of Psoriasis Treatment Modalities in Malaysia.Int J Health Policy Manag. 2019 Jul 1;8(7):394-402. doi: 10.15171/ijhpm.2019.17. Int J Health Policy Manag. 2019. PMID: 31441276 Free PMC article.
-
Mapping Dermatology Life Quality Index (DLQI) scores to EQ-5D utility scores using data of patients with atopic dermatitis from the National Health and Wellness Study.Qual Life Res. 2020 Sep;29(9):2529-2539. doi: 10.1007/s11136-020-02499-1. Epub 2020 Apr 15. Qual Life Res. 2020. PMID: 32297132 Free PMC article.
-
Comparing EQ-5D-5L, PROPr, SF-6D and TTO utilities in patients with chronic skin diseases.Eur J Health Econ. 2025 Jun;26(4):627-639. doi: 10.1007/s10198-024-01728-5. Epub 2024 Sep 28. Eur J Health Econ. 2025. PMID: 39340749 Free PMC article.
-
Severity and management of psoriasis within primary care.BMC Fam Pract. 2016 Oct 14;17(1):145. doi: 10.1186/s12875-016-0544-6. BMC Fam Pract. 2016. PMID: 27737638 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical